Lepidoglyphus Destructor Extract

This article discusses clinical trials using Lepidoglyphus Destructor Extract, a substance derived from house dust mites, for diagnosing allergies. The trials aim to determine the extract’s effectiveness in skin prick tests, which are commonly used to identify allergic reactions. Understanding these trials can help patients with suspected allergies to Lepidoglyphus destructor learn more about potential diagnostic methods.

Table of Contents

What is Lepidoglyphus Destructor?

Lepidoglyphus destructor is a type of mite that can cause allergic reactions in some people. These mites are commonly found in stored grains, hay, and house dust. When people with allergies are exposed to these mites, they may experience symptoms such as sneezing, runny nose, itchy eyes, or even asthma.[1]

Lepidoglyphus Destructor Extract

Lepidoglyphus destructor extract is a solution made from these mites. It is used in a medical test called a skin prick test to diagnose allergies. The extract is classified as an allergen extract, which means it contains substances that can trigger allergic reactions in sensitive individuals.[1]

Medical Conditions Treated

The Lepidoglyphus destructor extract is not a treatment itself, but rather a diagnostic tool. It is used to identify allergies to Lepidoglyphus destructor mites. Specifically, it can help diagnose:[1]

  • Allergic rhinitis (inflammation of the nasal passages, causing symptoms like sneezing and runny nose)
  • Allergic rhinoconjunctivitis (affecting both the nose and eyes)
  • Allergic asthma (breathing difficulties triggered by allergens)

How the Test Works

The test using Lepidoglyphus destructor extract is called a skin prick test. Here’s how it works:[1]

  1. A small drop of the extract is placed on the skin, usually on the forearm or back.
  2. The skin is then gently pricked through the drop.
  3. If you’re allergic to Lepidoglyphus destructor, a small, itchy bump (called a wheal) will form at the site within about 15-20 minutes.
  4. The size of this wheal is compared to the reaction produced by a substance called histamine, which is used as a control in the test.

The main goal of the study described is to determine the concentration of Lepidoglyphus destructor extract that produces a wheal equal in size to that produced by a 10 mg/mL histamine solution. This helps standardize the test and make results more reliable.[1]

Eligibility for the Test

To be eligible for this allergy test, patients typically need to meet the following criteria:[1]

  • Have a history of inhalant allergy symptoms (such as rhinitis, rhinoconjunctivitis, or asthma) when exposed to Lepidoglyphus destructor
  • Have had a previous positive skin prick test to Lepidoglyphus destructor (wheal diameter ≥ 3 mm) or have specific IgE antibodies to this allergen in their blood
  • Be between 18 and 64 years old
  • Be able to provide informed consent

There are additional requirements for women of childbearing age, including negative pregnancy tests and use of effective contraception methods during the study period.[1]

Exclusion Criteria

Certain conditions or circumstances may prevent a person from participating in this allergy test. These include:[1]

  • Pregnancy or breastfeeding
  • Known allergy to phenol (a preservative sometimes used in allergy extracts)
  • Recent immunotherapy for asthma or allergic rhinoconjunctivitis (within the last 5 years)
  • Severe allergy symptoms that prevent stopping antihistamine medications
  • History of severe reactions to skin prick tests
  • Use of beta-blocker medications
  • Unstable medical conditions (such as acute asthma or fever)
  • Skin conditions in the test area (like active urticaria, severe dermographism, atopic dermatitis, sunburn, eczema, or psoriasis)
  • Active herpes infections in the test area
  • Severe psychiatric disorders or inability to cooperate with the test procedure

Important Considerations

If you’re considering this allergy test, keep in mind:[1]

  • The test is for diagnostic purposes only and is not a treatment for allergies.
  • It’s important to inform your doctor about all medications you’re taking, as some may interfere with test results.
  • While skin prick tests are generally safe, there is a small risk of severe allergic reactions. The test should be performed by trained healthcare professionals in a setting equipped to handle such reactions.
  • A positive test result doesn’t always mean you’ll have symptoms when exposed to Lepidoglyphus destructor in real life. Your doctor will interpret the results in the context of your overall health and symptoms.
Aspect Details
Trial Name Lepidoglyphus destructor extract. Determination of in vivo allergenic potency in histamine equivalent prick testing units (HEP).
Trial Category Phase II clinical trial for the diagnosis of allergy to Lepidoglyphus destructor
Main Objective To assess the concentration of Lepidoglyphus destructor extract that induces a wheal equivalent to that produced by 10 mg/mL histamine dihydrochloride
Key Inclusion Criteria – Positive history of inhalant allergy to Lepidoglyphus destructor
– Positive prick-test or specific IgE to the allergen
– Age between 18 and 64 years
Key Exclusion Criteria – Pregnancy or breastfeeding
– Known phenol allergy
– Recent immunotherapy for asthma or allergic rhinoconjunctivitis
– Unstable clinical conditions
Drug Information – Name: Prick test of Lepidoglyphus destructor extract
– Form: Solution for skin-prick test
– Active Substance: Lepidoglyphus destructor extract

Ongoing Clinical Trials on Lepidoglyphus Destructor Extract

  • Study on Allergy to Lepidoglyphus Destructor: Testing with Lepidoglyphus Destructor Extract, Histamine Hydrochloride, and Sodium Chloride in Affected Patients

    Not recruiting

    2 1 1
    Spain

Glossary

  • Lepidoglyphus destructor: A species of house dust mite that can cause allergic reactions in some people.
  • Histamine dihydrochloride: A substance used as a reference in allergy skin prick tests to compare the reaction size of other allergens.
  • Wheal: A raised, itchy area on the skin that appears during an allergic reaction or after a skin prick test.
  • Skin prick test: A method used to diagnose allergies by placing a small amount of an allergen on the skin and then pricking the skin to see if a reaction occurs.
  • IgE (Immunoglobulin E): A type of antibody produced by the immune system that plays a key role in allergic reactions.
  • Rhinitis: Inflammation of the nasal passages, often causing symptoms like runny nose, sneezing, and congestion.
  • Rhinoconjunctivitis: A condition where both the nose and eyes are affected by allergic symptoms.
  • Allergen: A substance that can cause an allergic reaction in some people.
  • Immunotherapy: A treatment approach that aims to change how the immune system responds to allergens.
  • Antihistamine: A type of medication used to treat allergy symptoms by blocking the effects of histamine in the body.

References

  1. http://clinicaltrials.eu/trial/study-on-allergy-to-lepidoglyphus-destructor-testing-with-lepidoglyphus-destructor-extract-histamine-hydrochloride-and-sodium-chloride-in-affected-patients/